HomeCompareTEF vs JNJ

TEF vs JNJ: Dividend Comparison 2026

TEF yields 9.19% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $8.6K in total portfolio value· pulled ahead in Year 7
10 years
TEF
TEF
● Live price
9.19%
Share price
$3.81
Annual div
$0.35
5Y div CAGR
-41.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.9K
Annual income
$4.56
Full TEF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — TEF vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTEFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TEF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TEF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TEF
Annual income on $10K today (after 15% tax)
$780.84/yr
After 10yr DRIP, annual income (after tax)
$3.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $4,033.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TEF + JNJ for your $10,000?

TEF: 50%JNJ: 50%
100% JNJ50/50100% TEF
Portfolio after 10yr
$26.2K
Annual income
$2,377.22/yr
Blended yield
9.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TEF
Analyst Ratings
8
Buy
7
Hold
5
Sell
Consensus: Buy
Altman Z
0.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TEF buys
0
JNJ buys
0
No recent congressional trades found for TEF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTEFJNJ
Forward yield9.19%2.14%
Annual dividend / share$0.35$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-41.8%28%
Portfolio after 10y$21.9K$30.5K
Annual income after 10y$4.56$4,749.88
Total dividends collected$1.3K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TEF vs JNJ ($10,000, DRIP)

YearTEF PortfolioTEF Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,235$534.65$10,594$274.49+$641.00TEF
2$12,348$326.71$11,294$360.69+$1.1KTEF
3$13,407$195.31$12,133$476.91+$1.3KTEF
4$14,461$115.35$13,156$635.42+$1.3KTEF
5$15,541$67.68$14,432$854.61+$1.1KTEF
6$16,669$39.56$16,056$1,162.76+$613.00TEF
7← crossover$17,859$23.08$18,175$1,604.53$316.00JNJ
8$19,122$13.45$21,009$2,252.68$1.9KJNJ
9$20,469$7.83$24,911$3,229.73$4.4KJNJ
10$21,906$4.56$30,458$4,749.88$8.6KJNJ

TEF vs JNJ: Complete Analysis 2026

TEFStock

Telefónica, S.A., together with its subsidiaries, provides telecommunications services in Europe and Latin America. The company's mobile and related services and products comprise mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone services; local, domestic, and international long-distance and fixed-to-mobile communications; corporate communications; supplementary value-added services; video telephony; intelligent network; and telephony information services, as well as leases and sells handset equipment. The company also provides Internet and broadband multimedia services comprising Internet service provider, portal and network, retail and wholesale broadband access, narrowband switched access, high-speed Internet through fibre to the home, and voice over Internet protocol services. In addition, it offers leased line, virtual private network, fibre optics, web hosting and application, outsourcing and consultancy, desktop, and system integration and professional services. Further, the company offers wholesale services for telecommunication operators, including domestic interconnection and international wholesale services; leased lines for other operators; and local loop leasing services, as well as bit stream services, wholesale line rental accesses, and leased ducts for other operators' fiber deployment. Additionally, it provides video/TV services; smart connectivity and services, and consumer IoT products; financial and other payment, security, cloud computing, advertising, big data, and digital telco experience services; virtual assistants; digital home platforms; and Movistar Home devices. It also offers online telemedicine, home insurance, music streaming, and consumer loan services. The company was incorporated in 1924 and is headquartered in Madrid, Spain.

Full TEF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TEF vs SCHDTEF vs JEPITEF vs OTEF vs KOTEF vs MAINTEF vs ABBVTEF vs MRKTEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.